Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Breast Cancer Research : BCR|January 12, 2005
Do early premalignant changes in normal breast epithelial cells predict cancer development?Robert B Clarke, Nigel J BundredPlos One|March 5, 2013
Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 statusGillian Farnie, Pamela M Willan, Robert B Clarke, et al.Expert Opinion on Therapeutic Targets|September 17, 2013
Targeting IL-8 signalling to inhibit breast cancer stem cell activityJagdeep K Singh, Bruno M Simões, Robert B Clarke, et al.Stem Cells (Dayton, Ohio)|September 5, 2014
Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapyKathryn E Williams, Nigel J Bundred, Göran Landberg, et al.Cell Cycle (Georgetown, Tex.)|November 20, 2013
Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS)Gillian Farnie, Rachael L Johnson, Kathryn E Williams, et al.Breast Cancer Research : BCR|April 14, 2006
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivoFredrik Wärnberg, Daniel White, Elizabeth Anderson, et al.Women'S Health (London, England)|October 7, 2009
Letrozole: a well-tolerated and effective treatment for breast cancerNigel J BundredCurrent Opinion in Obstetrics & Gynecology|January 7, 2009
Aromatase inhibitors and bone healthNigel J BundredJournal of the National Cancer Institute|April 19, 2007
Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathwaysGillian Farnie, Robert B Clarke, Katherine Spence, et al.Pageof 14